238 related articles for article (PubMed ID: 33190177)
21. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
23. Copy Number Alterations Associated with Acute Lymphoblastic Leukemia in Mexican Children. A report from The Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia.
Rosales-Rodríguez B; Fernández-Ramírez F; Núñez-Enríquez JC; Velázquez-Wong AC; Medina-Sansón A; Jiménez-Hernández E; Flores-Lujano J; Peñaloza-González JG; Espinosa-Elizondo RM; Pérez-Saldívar ML; Torres-Nava JR; Martín-Trejo JA; Martínez-Morales GB; Bekker-Méndez VC; Mejía-Aranguré JM; Rosas-Vargas H
Arch Med Res; 2016 Nov; 47(8):706-711. PubMed ID: 28476198
[TBL] [Abstract][Full Text] [Related]
24. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
Bokemeyer A; Eckert C; Meyr F; Koerner G; von Stackelberg A; Ullmann R; Türkmen S; Henze G; Seeger K
Haematologica; 2014 Apr; 99(4):706-14. PubMed ID: 24241490
[TBL] [Abstract][Full Text] [Related]
25. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
[TBL] [Abstract][Full Text] [Related]
26. Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
Steinemann D; Cario G; Stanulla M; Karawajew L; Tauscher M; Weigmann A; Göhring G; Ludwig WD; Harbott J; Radlwimmer B; Bartram C; Lichter P; Schrappe M; Schlegelberger B
Genes Chromosomes Cancer; 2008 Jun; 47(6):471-80. PubMed ID: 18311775
[TBL] [Abstract][Full Text] [Related]
27. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
Yu CH; Lin TK; Jou ST; Lin CY; Lin KH; Lu MY; Chen SH; Cheng CN; Wu KH; Wang SC; Chang HH; Li MJ; Ni YL; Su YN; Lin DT; Chen HY; Harrison CJ; Hung CC; Lin SW; Yang YL
Sci Rep; 2020 Jul; 10(1):11501. PubMed ID: 32661308
[TBL] [Abstract][Full Text] [Related]
28. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.
Harvey RC; Mullighan CG; Wang X; Dobbin KK; Davidson GS; Bedrick EJ; Chen IM; Atlas SR; Kang H; Ar K; Wilson CS; Wharton W; Murphy M; Devidas M; Carroll AJ; Borowitz MJ; Bowman WP; Downing JR; Relling M; Yang J; Bhojwani D; Carroll WL; Camitta B; Reaman GH; Smith M; Hunger SP; Willman CL
Blood; 2010 Dec; 116(23):4874-84. PubMed ID: 20699438
[TBL] [Abstract][Full Text] [Related]
30. Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Fedullo AL; Messina M; Elia L; Piciocchi A; Gianfelici V; Lauretti A; Soddu S; Puzzolo MC; Minotti C; Ferrara F; Martino B; Chiusolo P; Calafiore V; Paolini S; Vignetti M; Vitale A; Guarini A; Foà R; Chiaretti S
Haematologica; 2019 Feb; 104(2):312-318. PubMed ID: 30190342
[TBL] [Abstract][Full Text] [Related]
31. Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations.
Antić Ž; Yu J; Van Reijmersdal SV; Van Dijk A; Dekker L; Segerink WH; Sonneveld E; Fiocco M; Pieters R; Hoogerbrugge PM; Van Leeuwen FN; Van Kessel AG; Waanders E; Kuiper RP
Haematologica; 2021 Dec; 106(12):3046-3055. PubMed ID: 33147938
[TBL] [Abstract][Full Text] [Related]
32. IKZF1
Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
[TBL] [Abstract][Full Text] [Related]
33. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
[TBL] [Abstract][Full Text] [Related]
34. Novel agents and biomarkers for acute lymphoid leukemia.
Zhao Y; Huang H; Wei G
J Hematol Oncol; 2013 Jun; 6():40. PubMed ID: 23773228
[TBL] [Abstract][Full Text] [Related]
35. TP53 alterations in relapsed childhood acute lymphoblastic leukemia.
Yu CH; Chang WT; Jou ST; Lin TK; Chang YH; Lin CY; Lin KH; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Su YN; Hung CC; Lin DT; Chen HY; Yang YL
Cancer Sci; 2020 Jan; 111(1):229-238. PubMed ID: 31729120
[TBL] [Abstract][Full Text] [Related]
36. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
Liu YF; Wang BY; Zhang WN; Huang JY; Li BS; Zhang M; Jiang L; Li JF; Wang MJ; Dai YJ; Zhang ZG; Wang Q; Kong J; Chen B; Zhu YM; Weng XQ; Shen ZX; Li JM; Wang J; Yan XJ; Li Y; Liang YM; Liu L; Chen XQ; Zhang WG; Yan JS; Hu JD; Shen SH; Chen J; Gu LJ; Pei D; Li Y; Wu G; Zhou X; Ren RB; Cheng C; Yang JJ; Wang KK; Wang SY; Zhang J; Mi JQ; Pui CH; Tang JY; Chen Z; Chen SJ
EBioMedicine; 2016 Jun; 8():173-183. PubMed ID: 27428428
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.
Bhandari P; Ahmad F; Das BR
Med Oncol; 2017 May; 34(5):92. PubMed ID: 28401483
[TBL] [Abstract][Full Text] [Related]
38. MLPA is a powerful tool for detecting lymphoblastic transformation in chronic myeloid leukemia and revealing the clonal origin of relapse in pediatric acute lymphoblastic leukemia.
Alpár D; de Jong D; Savola S; Yigittop H; Kajtár B; Kereskai L; Pajor L; Szuhai K
Cancer Genet; 2012 Sep; 205(9):465-9. PubMed ID: 22939399
[TBL] [Abstract][Full Text] [Related]
39. CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia.
Inthal A; Zeitlhofer P; Zeginigg M; Morak M; Grausenburger R; Fronkova E; Fahrner B; Mann G; Haas OA; Panzer-Grümayer R
Leukemia; 2012 Aug; 26(8):1797-803. PubMed ID: 22388726
[TBL] [Abstract][Full Text] [Related]
40. Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.
Forero-Castro M; Robledo C; Benito R; Abáigar M; África Martín A; Arefi M; Fuster JL; de Las Heras N; Rodríguez JN; Quintero J; Riesco S; Hermosín L; de la Fuente I; Recio I; Ribera J; Labrador J; Alonso JM; Olivier C; Sierra M; Megido M; Corchete-Sánchez LA; Ciudad Pizarro J; García JL; Ribera JM; Hernández-Rivas JM
PLoS One; 2016; 11(2):e0148972. PubMed ID: 26872047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
